Alkami Ends Strategic Review Without Sale, Shares Plunge 19% Premarket
ALKT is trading near its 52-week low of $13.98 (11% above the low).
Summary
Alkami Technology concluded its strategic review and will remain an independent public company, abandoning a potential sale. The stock fell 19% premarket to $14.74 as investors who had positioned for a takeover exit. The company reiterated full-year guidance of $528M-$531M revenue and $96M-$98M adjusted EBITDA, signaling confidence in its standalone plan. This follows activist investor JANA Partners' 6.3% stake disclosed in June, which likely pressured the review. The decision removes a near-term acquisition premium, but the reiterated guidance and $100M buyback program provide some support.
At the time of this announcement, ALKT was trading at $15.48 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $13.98 to $26.42. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.